NCT03724292View on ClinicalTrials.gov

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

March 8, 2016

Study Completion Date

March 8, 2016

Conditions
Psoriasis
Interventions
DRUG

Placebo

Dose-matched placebo administered as oral capsule(s) once daily

DRUG

VTP-43742

VTP-43742 administered as oral capsule(s) once daily

Trial Locations (1)

07410

Healthy Volunteer Site 1, Fair Lawn

All Listed Sponsors
lead

Vitae Pharmaceuticals Inc., an Allergan affiliate

INDUSTRY

NCT03724292 - An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers | Biotech Hunter | Biotech Hunter